Pediatric nonclinical drug testing : principles, requirements, and practices /

This book explains the importance and practice of pediatric drug testing for pharmaceutical and toxicology professionals. It describes the practical and ethical issues regarding non-clinical testing to meet US FDA Guidelines, differences resulting from the new European EMEA legislation, and how to d...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Άλλοι συγγραφείς: Hoberman, Alan M., Lewis, Elise M.
Μορφή: Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Hoboken, N.J. : John Wiley & Sons, [2012]
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 04591nam a2200697 4500
001 ocn794822665
003 OCoLC
005 20170124071418.4
006 m o d
007 cr |n|||||||||
008 111018s2012 njua ob 001 0 eng d
040 |a MERUC  |b eng  |e pn  |c MERUC  |d DG1  |d TXA  |d OCLCQ  |d COO  |d DKDLA  |d OCLCO  |d NLGGC  |d NLE  |d OCLCQ  |d S3O  |d OCLCQ  |d DEBBG  |d GrThAP 
019 |a 775437893  |a 860515287 
020 |a 9780470448618  |q (cloth) 
020 |a 047044861X  |q (cloth) 
020 |a 9781118168226  |q (electronic bk.) 
020 |a 1118168224  |q (electronic bk.) 
020 |a 9781280590429  |q (MyiLibrary) 
020 |a 1280590424  |q (MyiLibrary) 
024 8 |a 9786613620255 
029 1 |a DKDLA  |b 820120-katalog:000600377 
029 1 |a GBVCP  |b 79003722X 
029 1 |a NZ1  |b 15915772 
029 1 |a DEBBG  |b BV043394583 
035 |a (OCoLC)794822665  |z (OCoLC)775437893  |z (OCoLC)860515287 
037 |a 362025  |b MIL 
043 |a n-us--- 
050 4 |a RJ560  |b .P43 2012eb 
060 4 |a 2012 E-065 
060 4 |a QV 771 
082 0 4 |a 615.7/040287  |2 23 
049 |a MAIN 
245 0 0 |a Pediatric nonclinical drug testing :  |b principles, requirements, and practices /  |c edited by Alan M. Hoberman, Elise M. Lewis. 
246 3 |a Pediatric non-clinical drug testing 
264 1 |a Hoboken, N.J. :  |b John Wiley & Sons,  |c [2012] 
264 4 |c ©2012 
300 |a 1 online resource (xv, 339 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references and index. 
588 0 |a Print version record. 
505 0 |a Introduction / Elise M Lewis, Luc M De Schaepdrijver, Timothy P Coogan -- Overview of Pediatric Diseases and Clinical Considerations on Developing Medicines for Children / Bert Suys, Jose Ramet -- Nonclinical Safety Assessment for Biopharmaceuticals: Challenges and Strategies for Juvenile Animal Testing / Timothy P Coogan -- FDA Approach to Pediatric Testing / Robert E Osterberg -- Pediatric Drug Development Plans / Kimberly C Brannen, Beatriz Silva Lima -- Application of Principles of Nonclinical Pediatric Drug Testing to the Hazard Evaluation of Environmental Contaminants / Susan L Makris -- Nonclinical Testing Procedures-Pharmacokinetics / Loeckie L de Zwart, Johan G Monbaliu, Pieter P Annaert -- Preclinical Development of a Pharmaceutical Product for Children / Graham P Bailey, Timothy P Coogan, Luc M De Schaepdrijver -- Juvenile Toxicity Study Design for the Rodent and Rabbit / Alan M Hoberman, John F Barnett -- Dog Juvenile Toxicity / Keith Robinson, Susan Y Smith, Andre Viau -- Use of the Swine Pediatric Model / Paul C Barrow -- Juvenile Immunodevelopment in Minipigs / Andre H Penninks, Geertje J D van Mierlo, Frieke Kuper, Cor J Snel, Niels-Christian Ganderup, Andre P M Wolterbeek -- Use of Primate Pediatric Model / Gerhard F Weinbauer, Gary J Chellman, Allan Dahl Rasmussen, Elvira Vogelwedde -- Approaches to Rat Juvenile Toxicity Studies and Case Studies: a Pharmaceutical Perspective / Susan B Laffan, Lorraine Posobiec -- Appendix 1: Maturation of Organ Systems in Various Species -- Appendix 2: Sample Juvenile Toxicity Testing Protocol. 
520 8 |a This book explains the importance and practice of pediatric drug testing for pharmaceutical and toxicology professionals. It describes the practical and ethical issues regarding non-clinical testing to meet US FDA Guidelines, differences resulting from the new European EMEA legislation, and how to develop appropriate information for submission to both agencies. It also provides practical study designs and approaches that can be used to meet international requirements. Covering the full scope of non-clinical testing, regulations, models, practice, and relation to clinical trials, this text offers a comprehensive and up-to-date resource"--Provided by publisher. 
650 0 |a Pediatric pharmacology  |x Research  |z United States. 
650 0 |a Drugs  |x Toxicology  |z United States. 
650 2 |a Drug Evaluation, Preclinical. 
650 2 |a Age Factors. 
650 2 |a Child. 
650 2 |a Drug Approval. 
650 2 |a Drug Toxicity  |x prevention & control. 
650 2 |a Infant. 
650 2 |a Models, Animal. 
650 7 |a Läkemedelsutveckling.  |2 sao 
651 2 |a United States. 
655 4 |a Electronic books. 
700 1 |a Hoberman, Alan M. 
700 1 |a Lewis, Elise M. 
776 0 8 |i Print version:  |z 9780470448618  |w (OCoLC)757912391 
856 4 0 |u https://doi.org/10.1002/9781118168226  |z Full Text via HEAL-Link 
994 |a 92  |b DG1